"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are re...

This is the second drug developed by Hetero after Covifor, the generic version of Remdesivir injection to be administered intravenously in ...

Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitali...

The drug controller has said that the importer of the drug (Gilead pharma) took an import licence on 1st of June and is yet to supply the d...

Gilead has issued licences to nine generic drug companies to make and sell remdesivir. Six of the companies are Indian - Hetero, Cipla, Dr ...

The Hyderabad-headquartered Hetero said it will dispatch second batch of 10,000 vials of the generic drug in the injectable form (100mg via...

The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to ...

Hetero will produce and launch the first generic Remdesivir under Covifor brand in India following positive clinical outcomes under a licen...

Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in th...

The product will be marketed by Hetero Healthcare under the brand name ‘MaburaTM’ in India, the company said.

The FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in ...

The company "has received the approval for the generic version of 'Sofosbuvir+Velpatasvir' combination from the Drugs Controller General of...

Hetero has launched biosimilar Rituximab in India used for treatment of certain types of cancers and rheumatoid arthritis under the brand n...

Hetero has dedicated manufacturing facilities at Visakhapatnam in Andhra Pradesh and Baddi in Himachal Pradesh exclusively to produce the d...

Apollo Hospitals Enterprise expects to leverage on it's proven track record of performance and operational capabilities to drive growth and...

Hyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...

Organised pharma retail, dominated by the likes of Apollo and Subiksha, is set for more action at the regional level.